翔宇医疗业绩快报：2024年净利润同比减少54.44%

Core Viewpoint - Xiangyu Medical (688626) reported a decline in both revenue and net profit for the fiscal year 2024, indicating challenges in maintaining profitability despite ongoing investments in talent and infrastructure [1] Financial Performance - The total operating revenue for 2024 was 744 million yuan, a year-on-year decrease of 0.17% [1] - The net profit attributable to the parent company was 103 million yuan, reflecting a significant year-on-year decline of 54.44% [1] - Basic earnings per share stood at 0.66 yuan [1] Operational Insights - The company has been actively recruiting high-end rehabilitation technology talents and significantly increasing the number of research and development personnel [1] - Increased salaries and related expenses for R&D personnel contributed to the decline in net profit [1] - The depreciation and amortization expenses rose compared to the previous year due to the gradual commissioning of construction projects [1]